Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthstream (HSTM) Cost of Revenue (2016 - 2025)

Healthstream (HSTM) has disclosed Cost of Revenue for 16 consecutive years, with $43.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 31.69% to $43.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $107.2 million, a 9.47% increase, with the full-year FY2025 number at $107.2 million, up 9.47% from a year prior.
  • Cost of Revenue was $43.2 million for Q4 2025 at Healthstream, up from $12.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $63.3 million in Q4 2024 to a low of -$23.5 million in Q4 2022.
  • A 5-year average of $23.0 million and a median of $22.1 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: tumbled 147.76% in 2022, then soared 358.73% in 2023.
  • Healthstream's Cost of Revenue stood at $49.1 million in 2021, then plummeted by 147.76% to -$23.5 million in 2022, then soared by 358.73% to $60.7 million in 2023, then rose by 4.22% to $63.3 million in 2024, then crashed by 31.69% to $43.2 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Cost of Revenue are $43.2 million (Q4 2025), $12.1 million (Q3 2025), and $39.7 million (Q2 2025).